Human Serum Antibodies to a Major Defined Epitope of Human Herpesvirus 8 Small Viral Capsid Antigen

The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among ∼50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subje...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 179; no. 4; pp. 1016 - 1020
Main Authors Tedeschi, Rosamaria, De Paoli, Paolo, Schulz, Thomas F., Dillner, Joakim
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.04.1999
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among ∼50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.
AbstractList The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among approximately 50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.
The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among similar to 50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.
The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among ~50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.
The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among approximately 50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among approximately 50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.
The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong IgG reactivity was found among ∼50% of 44 human immunodeficiency virus-positive or -negative patients with Kaposi's sarcoma and 13 subjects who were seropositive by immunofluorescence assay (IFA) for the latent HHV-8 nuclear antigen. Only 1 of 106 subjects seronegative for both lytic and latent HHV-8 antigens and 10 of 81 subjects IFA-seropositive only for the lytic HHV-8 antigen had strong IgG reactivity to this epitope. Among 534 healthy Swedish women, only 1.3% were strongly seropositive. Comparison of the peptide-based and purified sVCA protein-based ELISAs found 55% sensitivity and 98% specificity. However, only 1 of 452 serum samples from healthy women was positive in both tests. In conclusion, the defined sVCA epitope was a specific, but not very sensitive, serologic marker of active HHV-8 infection. Such infection appears to be rare among Swedish women, even with sexual risk-taking behavior.
Author De Paoli, Paolo
Tedeschi, Rosamaria
Schulz, Thomas F.
Dillner, Joakim
Author_xml – sequence: 1
  givenname: Rosamaria
  surname: Tedeschi
  fullname: Tedeschi, Rosamaria
  email: micro@ets.it
  organization: Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Aviano, Liverpool, Sweden, Italy, United Kingdom
– sequence: 2
  givenname: Paolo
  surname: De Paoli
  fullname: De Paoli, Paolo
  organization: Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Aviano, Liverpool, Sweden, Italy, United Kingdom
– sequence: 3
  givenname: Thomas F.
  surname: Schulz
  fullname: Schulz, Thomas F.
  organization: Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Aviano, Liverpool, Sweden, Italy, United Kingdom
– sequence: 4
  givenname: Joakim
  surname: Dillner
  fullname: Dillner, Joakim
  organization: Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Aviano, Liverpool, Sweden, Italy, United Kingdom
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1772010$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10068601$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:1946691$$DView record from Swedish Publication Index
BookMark eNqF0l1vFCEUBmBiauy26j_QkMZ45egBZmG4bLbVNa5fqTaNN4QBxrCdGUZg_Pj3ju66a-qFVxB4eHMOcIQO-tA7hO4TeEqg4s8YKflc3EIzMmei4JywAzQDoLQglZSH6CilNQCUjIs76JAA8IoDmSGzHDvd4wsXxw6f9tnXwXqXcA5Y49d6HSI-c43vncXng89hcDg0eHNo6eLg0lcfx4QrfNHptsWXPuoWL_SQvP2d99n1d9HtRrfJ3duOx-jj8_MPi2Wxevvi5eJ0VZiSQy5kNa9Zw6ktLbOWkKauSW20YSCF5ELzhjiwtOS0dpa4BoympZaVNVVJiZbsGBWb3PTNDWOthug7HX-ooL3aLl1PM6c4cCrJ5B9v_BDDl9GlrDqfjGtb3bswJsUlJ8DE_yERlFFCqgme3IDrMMZ-alpRyiRUsoIJPdyise6c3ZX551Em8GgLdDK6baLujU97JwQFAvuqTAwpRdf8laR-fQq1-RQTfHIDGp919qHPUfv2X_5gw9cph7gLZUCmFmm5v2afsvu-29fxWnHBxFwtrz6p968u-Zt3Z1dqxX4Cs4vNpw
CODEN JIDIAQ
CitedBy_id crossref_primary_10_1016_S0166_0934_01_00289_0
crossref_primary_10_1099_vir_0_027847_0
crossref_primary_10_1081_NCN_120026633
crossref_primary_10_1128_JVI_75_6_2879_2890_2001
crossref_primary_10_1002_jmv_1081
crossref_primary_10_38053_agtd_578356
crossref_primary_10_1007_s11908_999_0031_5
crossref_primary_10_1002_jmv_20549
crossref_primary_10_1097_00007435_200204000_00004
crossref_primary_10_1007_s10096_002_0836_8
crossref_primary_10_1128_JCM_38_2_696_701_2000
crossref_primary_10_1128_JCM_39_12_4269_4273_2001
crossref_primary_10_1002_1097_0215_20000715_87_2_232__AID_IJC13_3_0_CO_2_T
crossref_primary_10_1016_S1386_6532_99_00085_2
crossref_primary_10_1016_S0037_1963_03_70005_5
crossref_primary_10_1128_CDLI_7_3_427_435_2000
crossref_primary_10_1128_JVI_74_8_3478_3485_2000
ContentType Journal Article
Copyright Copyright 1999 Infectious Diseases Society of America
1999 INIST-CNRS
Copyright University of Chicago, acting through its Press Apr 1999
Copyright_xml – notice: Copyright 1999 Infectious Diseases Society of America
– notice: 1999 INIST-CNRS
– notice: Copyright University of Chicago, acting through its Press Apr 1999
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7U9
H94
7X8
ADTPV
AOWAS
DOI 10.1086/314657
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
SwePub
SwePub Articles
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE
AIDS and Cancer Research Abstracts

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 1020
ExternalDocumentID oai_swepub_ki_se_606291
40323341
10068601
1772010
10_1086_314657
30111824
ark_67375_HXZ_QKV6NPDX_L
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
3O-
4.4
41~
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAFWJ
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
ABBHK
ABDFA
ABDPE
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACGOD
ACHIC
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFQV
AFFZL
AFHKK
AFIYH
AFOFC
AFQQW
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGORE
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
APWMN
AQDSO
AQKUS
AQVQM
ATGXG
AVNTJ
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BSCLL
BTRTY
BVRKM
BZKNY
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
MBLQV
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P0-
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TR2
VH1
W2D
W8F
WH7
X7H
X7M
Y6R
YAYTL
YKOAZ
YXANX
ZE2
ZGI
ZXP
~91
AAYOK
AAYXX
CITATION
IQODW
6.Y
ABSAR
ADJQC
ADRIX
AFXEN
CGR
CUY
CVF
DOOOF
ECM
EIF
ESX
JSODD
M49
NPM
VXZ
YIF
ZKG
K9.
NAPCQ
7U9
H94
7X8
ADTPV
AOWAS
ID FETCH-LOGICAL-c460t-985b3f62d4d3dd11fbb1bcac3097967a6f1e0d2462bed1ef0ca24a98dc8421a93
ISSN 0022-1899
IngestDate Mon Sep 01 03:31:39 EDT 2025
Fri Jul 11 06:33:14 EDT 2025
Thu Jul 10 17:27:44 EDT 2025
Mon Jun 30 10:55:50 EDT 2025
Wed Feb 19 01:20:36 EST 2025
Mon Jul 21 09:17:32 EDT 2025
Tue Jul 01 03:23:19 EDT 2025
Thu Apr 24 23:00:11 EDT 2025
Fri Jun 20 02:32:13 EDT 2025
Tue Aug 05 16:49:53 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Gammaherpesvirinae
Performance evaluation
Human
Immunopathology
Skin disease
Antigenic determinant
Nucleotide sequence
Herpesviridae
AIDS
Serology
Malignant tumor
Immune deficiency
Open reading frame
Herpesvirus hominis 8
Infection
Virus
Kaposi sarcoma
Viral disease
Diagnosis
Capsid
Aminoacid sequence
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c460t-985b3f62d4d3dd11fbb1bcac3097967a6f1e0d2462bed1ef0ca24a98dc8421a93
Notes istex:79950C2C6534EB48CB7EF2D8BA3108E907E441A9
ark:/67375/HXZ-QKV6NPDX-L
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 10068601
PQID 223908980
PQPubID 41591
PageCount 5
ParticipantIDs swepub_primary_oai_swepub_ki_se_606291
proquest_miscellaneous_69610371
proquest_miscellaneous_17232118
proquest_journals_223908980
pubmed_primary_10068601
pascalfrancis_primary_1772010
crossref_primary_10_1086_314657
crossref_citationtrail_10_1086_314657
jstor_primary_30111824
istex_primary_ark_67375_HXZ_QKV6NPDX_L
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1999-04-01
PublicationDateYYYYMMDD 1999-04-01
PublicationDate_xml – month: 04
  year: 1999
  text: 1999-04-01
  day: 01
PublicationDecade 1990
PublicationPlace Chicago, IL
PublicationPlace_xml – name: Chicago, IL
– name: United States
– name: Oxford
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate The Journal of Infectious Diseases
PublicationYear 1999
Publisher The University of Chicago Press
University of Chicago Press
Oxford University Press
Publisher_xml – name: The University of Chicago Press
– name: University of Chicago Press
– name: Oxford University Press
SSID ssj0004367
Score 1.6754293
Snippet The major antibody-reactive epitope of the small viral capsid antigen (sVCA) of human herpesvirus 8 (HHV-8) was defined by use of overlapping peptides. Strong...
SourceID swepub
proquest
pubmed
pascalfrancis
crossref
jstor
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1016
SubjectTerms Adolescent
Amino Acid Sequence
Antibodies
Antibodies, Viral - blood
Antigens
Antigens, Viral - immunology
Biological and medical sciences
Blood donation
Capsid - immunology
Concise Communications
Enzyme-Linked Immunosorbent Assay
Epitopes
Female
Fundamental and applied biological sciences. Psychology
Herpesviridae
Herpesvirus 8, Human - immunology
Human herpesvirus 8
Human immunodeficiency virus
Human viral diseases
Humans
Immunoglobulin G - blood
Infections
Infectious diseases
Kaposi sarcoma
Medical sciences
Microbiology
Molecular Sequence Data
Reactivity
Sensitivity and Specificity
Techniques used in virology
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Virology
Title Human Serum Antibodies to a Major Defined Epitope of Human Herpesvirus 8 Small Viral Capsid Antigen
URI https://api.istex.fr/ark:/67375/HXZ-QKV6NPDX-L/fulltext.pdf
https://www.jstor.org/stable/30111824
https://www.ncbi.nlm.nih.gov/pubmed/10068601
https://www.proquest.com/docview/223908980
https://www.proquest.com/docview/17232118
https://www.proquest.com/docview/69610371
http://kipublications.ki.se/Default.aspx?queryparsed=id:1946691
Volume 179
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTSBeEAwGZYz5AfZSZUpix0keEdtUugsgdajiJXJsB7q1TdULgv0ifibHlyYpbAh4iSzbjZ2ez_ax_Z1zEHpJuB_JWAov5lR6NC4iL5Vx7okolX5OiAgNefzsnHUvaG8QDVqtHw3W0nKRH4jrG-1K_keqkAdy1Vay_yDZ6qWQAWmQLzxBwvD8KxnbE3hoSjOMJ4thXmpOoFYneWfML0sd_LsANVJ21BRG7tScD9iofCCqqZp_Hc6W807SmY_1DbXm-446gk_hS8z7Pjs7scsaUr2mpwnL44I3uGueSj_vc6lg2zy03O05H3PLZrY6swK9tbRm2TpR1pdBX5aj65q2VLOOD4ejkbPM6ZWg847rwwrr4IA2DytuMYJsTtCwNw4SGzPpQK3m5NgDNYKsTdo2BI1DJ21Mwfo44sa1wTdXVQSWBusSe9359vm77Pji9DTrHw3666Vmsac-CQnRHhI2Q9iQ6FgZh29PagtcwuKVX3rd_UYUK9vgmtqzqUfwtxUDVtNx-RxGZGFDqdy01_nFka1RfvoP0H0ndPzaQvAhaqnJFrpj45h-30J3zxxD4xESBpPYYBLXmMSLEnNsMIkdJrHDJC4LbDCJG5jECTaYxAaT2GISO0w-RhfHR_03Xc8F8vAEZf7CS5MoJwULJZVEyiAo8jzIBRfET-OUxZwVgfJlSFmYKxmowhc8pDxNpEhoGPCUbKONSTlRTxEOhEiKRMpIpgWlUKmIBFGMEO3pMg_8Nnq1-p8z4bzc62Aro8ywLRKWWXm00V5Vb2r9uvxWY9-IqSrmsyvNgoyjrDv4lH04-cjO3x8OstM22jZyrCrqNRO27bSNdtcEWzcECPJ1X3dWgs7crDLPQF3XV_EJlO5VpTDl63s8PlEwpuHnsA2CFm6vwVKm7X-DNnpi8dP4Rm0T5kPJvgVUVaL9zLusK0ipjPksTINnf-zkDrpXD_PnaGMxW6pd0NIX-QszQH4C4IbsaA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+serum+antibodies+to+a+major+defined+epitope+of+human+herpesvirus+8+small+viral+capsid+antigen&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Tadeschi%2C+Rosamaria&rft.au=De+Paoli%2C+Paolo&rft.au=Schulz%2C+Thomas+F&rft.au=Dillner%2C+Joakim&rft.date=1999-04-01&rft.pub=Oxford+University+Press&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=179&rft.issue=4&rft.spage=1016&rft_id=info:doi/10.1086%2F314657&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=40323341
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon